CathWorks: Optimizing PCI Therapy Decisions
CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize PCI therapy decisions and elevate coronary angiography from visual assessment to an objective FFR-based decision-making tool for physicians.
FFR-guided PCI decision-making is proven to provide significant clinical benefits for patients with coronary artery disease and economic benefits for patients and payers. Our focus today is specifically on bringing the CathWorks FFRangio™ System to market to provide quick, precise, and objective intraprocedural FFR guidance that is practical for every case.
The CathWorks leadership team is comprised of seasoned medical and technology industry executives who have held major positions at leading healthcare and IT companies.
Board of Directors
The CathWorks board of directors represents extensive experience and accomplishments in cardiovascular business, science, and medicine.
Former Senior Vice President and President of the Cardiovascular Business of Medtronic Inc.